Hoxton Planning & Management LLC Trims Stock Position in CVS Health Co. (NYSE:CVS)

Hoxton Planning & Management LLC lessened its stake in shares of CVS Health Co. (NYSE:CVS) by 30.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,650 shares of the pharmacy operator’s stock after selling 1,598 shares during the quarter. Hoxton Planning & Management LLC’s holdings in CVS Health were worth $288,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Live Oak Investment Partners purchased a new stake in shares of CVS Health during the 4th quarter worth approximately $25,000. Atticus Wealth Management LLC increased its holdings in shares of CVS Health by 149.0% in the 4th quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock valued at $29,000 after acquiring an additional 219 shares during the period. Cornerstone Planning Group LLC increased its holdings in shares of CVS Health by 111.5% in the 3rd quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 243 shares during the period. PCA Investment Advisory Services Inc. acquired a new position in shares of CVS Health in the 2nd quarter valued at $37,000. Finally, ZRC Wealth Management LLC increased its holdings in shares of CVS Health by 400.0% in the 4th quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator’s stock valued at $39,000 after acquiring an additional 400 shares during the period. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the stock. Royal Bank of Canada cut their target price on shares of CVS Health from $86.00 to $84.00 and set an “outperform” rating on the stock in a report on Thursday, February 8th. Cantor Fitzgerald reissued an “overweight” rating and issued a $87.00 price objective on shares of CVS Health in a research note on Wednesday, April 10th. StockNews.com cut shares of CVS Health from a “buy” rating to a “hold” rating in a research note on Thursday, February 15th. Barclays started coverage on shares of CVS Health in a research note on Wednesday, March 6th. They issued an “equal weight” rating and a $78.00 price objective on the stock. Finally, Leerink Partnrs reissued an “outperform” rating on shares of CVS Health in a research note on Monday, February 26th. Four analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $89.44.

CVS Health Stock Up 1.4 %

Shares of CVS Health stock traded up $0.99 on Monday, hitting $69.63. 2,588,516 shares of the company’s stock traded hands, compared to its average volume of 10,894,256. The stock has a market cap of $87.77 billion, a P/E ratio of 10.67, a PEG ratio of 0.91 and a beta of 0.52. The company has a quick ratio of 0.63, a current ratio of 0.86 and a debt-to-equity ratio of 0.77. The firm’s 50-day moving average is $75.85 and its 200 day moving average is $73.78. CVS Health Co. has a 52-week low of $64.41 and a 52-week high of $83.25.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.01 by $0.11. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. The firm had revenue of $93.81 billion for the quarter, compared to analysts’ expectations of $90.58 billion. During the same period last year, the business posted $1.99 earnings per share. The firm’s revenue for the quarter was up 11.9% on a year-over-year basis. Equities analysts anticipate that CVS Health Co. will post 8.33 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd will be paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 3.82%. The ex-dividend date of this dividend is Friday, April 19th. CVS Health’s payout ratio is 41.18%.

Insider Buying and Selling at CVS Health

In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of the firm’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of $76.95, for a total value of $2,267,947.35. Following the sale, the executive vice president now directly owns 39,765 shares in the company, valued at $3,059,916.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.24% of the stock is currently owned by company insiders.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.